ReP USP - Resultado da busca

Artigo de periodico
Chronic activation profile of circulating CD8+T cells in Sezary syndrome (2018)
Torrealba, Marina Passos; Pereira, Juliana; Duarte, Alberto J. S.; Sato, Maria N.
Source: Oncotarget. Unidade: FM
Subjects: NEOPLASIAS CUTÂNEAS, LINFÓCITOS T, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TORREALBA, Marina Passos et al. Chronic activation profile of circulating CD8+T cells in Sezary syndrome. Oncotarget, v. 9, n. 3, p. 3497-3506, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.23334. Acesso em: 18 nov. 2024.
APA
Torrealba, M. P., Pereira, J., Duarte, A. J. S., & Sato, M. N. (2018). Chronic activation profile of circulating CD8+T cells in Sezary syndrome. Oncotarget, 9( 3), 3497-3506. doi:10.18632/oncotarget.23334
NLM
Torrealba MP, Pereira J, Duarte AJS, Sato MN. Chronic activation profile of circulating CD8+T cells in Sezary syndrome [Internet]. Oncotarget. 2018 ; 9( 3): 3497-3506.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.23334
Vancouver
Torrealba MP, Pereira J, Duarte AJS, Sato MN. Chronic activation profile of circulating CD8+T cells in Sezary syndrome [Internet]. Oncotarget. 2018 ; 9( 3): 3497-3506.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.23334
Artigo de periodico
Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer (2018)
Santos, Silvia Helena Rabelo ; Termini, Lara ; Boccardo, Enrique ; Derchain, Sophie Françoise Mauricette ; Longatto Filho, Adhemar ; Andreoli, Maria Antonieta Avilla; Costa, Maria Cecília; Nunes, Rafaella Almeida Lima ; Andrade, Liliana Aparecida Lucci de Ângelo ; Villa, Luisa Lina ; Zeferino, Luiz Carlos
Source: Oncotarget. Unidades: ICB, FM
Subjects: INFECÇÕES POR PAPILLOMAVIRUS, NEOPLASIAS DO COLO UTERINO, HPV, SUPERÓXIDO DISMUTASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Silvia Helena Rabelo et al. Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer. Oncotarget, v. 9, n. 31, p. 21630-21640, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.24850. Acesso em: 18 nov. 2024.
APA
Santos, S. H. R., Termini, L., Boccardo, E., Derchain, S. F. M., Longatto Filho, A., Andreoli, M. A. A., et al. (2018). Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer. Oncotarget, 9( 31), 21630-21640. doi:10.18632/oncotarget.24850
NLM
Santos SHR, Termini L, Boccardo E, Derchain SFM, Longatto Filho A, Andreoli MAA, Costa MC, Nunes RAL, Andrade LAL de Â, Villa LL, Zeferino LC. Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer [Internet]. Oncotarget. 2018 ; 9( 31): 21630-21640.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.24850
Vancouver
Santos SHR, Termini L, Boccardo E, Derchain SFM, Longatto Filho A, Andreoli MAA, Costa MC, Nunes RAL, Andrade LAL de Â, Villa LL, Zeferino LC. Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer [Internet]. Oncotarget. 2018 ; 9( 31): 21630-21640.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.24850
Artigo de periodico
Aptamers: novelty tools for cancer biology (2018)
Pereira, Ricardo L; Nascimento, Isis C; Santos, Ana P; Ogusuku, Isabella E. Y; Lameu, Claudiana ; Mayer, Günter; Ulrich, Henning
Source: Oncotarget. Unidade: IQ
Subjects: NEOPLASIAS, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Ricardo L et al. Aptamers: novelty tools for cancer biology. Oncotarget, v. 9, n. 42, p. 26934-26953, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25260. Acesso em: 18 nov. 2024.
APA
Pereira, R. L., Nascimento, I. C., Santos, A. P., Ogusuku, I. E. Y., Lameu, C., Mayer, G., & Ulrich, H. (2018). Aptamers: novelty tools for cancer biology. Oncotarget, 9( 42), 26934-26953. doi:10.18632/oncotarget.25260
NLM
Pereira RL, Nascimento IC, Santos AP, Ogusuku IEY, Lameu C, Mayer G, Ulrich H. Aptamers: novelty tools for cancer biology [Internet]. Oncotarget. 2018 ; 9( 42): 26934-26953.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25260
Vancouver
Pereira RL, Nascimento IC, Santos AP, Ogusuku IEY, Lameu C, Mayer G, Ulrich H. Aptamers: novelty tools for cancer biology [Internet]. Oncotarget. 2018 ; 9( 42): 26934-26953.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25260
Artigo de periodico
The role of E-cadherin and β-catenin in laryngeal cancer (2018)
Nardi, C. E; Dedivitis, R. A; Almeida, R. C; Matos, L. L. de; Cernea, Claudio Roberto
Source: Oncotarget. Unidade: FM
Subjects: NEOPLASIAS LARÍNGEAS, CADERINAS, CITOESQUELETO, IMUNOHISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDI, C. E et al. The role of E-cadherin and β-catenin in laryngeal cancer. Oncotarget, v. 9, n. 53, p. 30199-30209, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25680. Acesso em: 18 nov. 2024.
APA
Nardi, C. E., Dedivitis, R. A., Almeida, R. C., Matos, L. L. de, & Cernea, C. R. (2018). The role of E-cadherin and β-catenin in laryngeal cancer. Oncotarget, 9( 53), 30199-30209. doi:10.18632/oncotarget.25680
NLM
Nardi CE, Dedivitis RA, Almeida RC, Matos LL de, Cernea CR. The role of E-cadherin and β-catenin in laryngeal cancer [Internet]. Oncotarget. 2018 ; 9( 53): 30199-30209.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25680
Vancouver
Nardi CE, Dedivitis RA, Almeida RC, Matos LL de, Cernea CR. The role of E-cadherin and β-catenin in laryngeal cancer [Internet]. Oncotarget. 2018 ; 9( 53): 30199-30209.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25680
Artigo de periodico
Highly expressed placental miRNAs control key biological processes in human cancer cell lines (2018)
Vidal, Daniel Onofre; Ramão, Anelisa ; Pinheiro, Daniel Guariz; Muys, Bruna Rodrigues ; Lorenzi, Julio Cesar Cetrulo; Alves, Cleidson de Pádua; Zanette, Dalila Luciola; Molfetta, Greice Andreotti de ; Duarte, Geraldo ; Silva Junior, Wilson Araújo
Source: Oncotarget. Unidade: FMRP
Subjects: PLACENTA, CARCINOGÊNESE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDAL, Daniel Onofre et al. Highly expressed placental miRNAs control key biological processes in human cancer cell lines. Oncotarget, v. 9, n. 34, p. 23554-23563, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25264. Acesso em: 18 nov. 2024.
APA
Vidal, D. O., Ramão, A., Pinheiro, D. G., Muys, B. R., Lorenzi, J. C. C., Alves, C. de P., et al. (2018). Highly expressed placental miRNAs control key biological processes in human cancer cell lines. Oncotarget, 9( 34), 23554-23563. doi:10.18632/oncotarget.25264
NLM
Vidal DO, Ramão A, Pinheiro DG, Muys BR, Lorenzi JCC, Alves C de P, Zanette DL, Molfetta GA de, Duarte G, Silva Junior WA. Highly expressed placental miRNAs control key biological processes in human cancer cell lines [Internet]. Oncotarget. 2018 ; 9( 34): 23554-23563.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25264
Vancouver
Vidal DO, Ramão A, Pinheiro DG, Muys BR, Lorenzi JCC, Alves C de P, Zanette DL, Molfetta GA de, Duarte G, Silva Junior WA. Highly expressed placental miRNAs control key biological processes in human cancer cell lines [Internet]. Oncotarget. 2018 ; 9( 34): 23554-23563.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25264
Artigo de periodico
Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms (2018)
Rodini, Carolina Oliveira; Silva, Patrícia Benites Gonçalves da; Assoni, Amanda Faria ; Carvalho, Valdemir Melechco ; Okamoto, Oswaldo Keith
Source: Oncotarget. Unidade: IB
Subjects: CÉLULAS-TRONCO, TUMOR CARCINOIDE, NEOPLASIAS CEREBRAIS, GLICOPROTEÍNAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODINI, Carolina Oliveira et al. Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms. Oncotarget, v. 9, n. 37, p. 24766-24777, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25346. Acesso em: 18 nov. 2024.
APA
Rodini, C. O., Silva, P. B. G. da, Assoni, A. F., Carvalho, V. M., & Okamoto, O. K. (2018). Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms. Oncotarget, 9( 37), 24766-24777. doi:10.18632/oncotarget.25346
NLM
Rodini CO, Silva PBG da, Assoni AF, Carvalho VM, Okamoto OK. Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms [Internet]. Oncotarget. 2018 ; 9( 37): 24766-24777.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25346
Vancouver
Rodini CO, Silva PBG da, Assoni AF, Carvalho VM, Okamoto OK. Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms [Internet]. Oncotarget. 2018 ; 9( 37): 24766-24777.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25346
Artigo de periodico
Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology (2018)
Pavon, Lorena Favaro; Sibov, Tatiana Tais; Toledo, Silvia Regina Caminada de; Oliveira, Daniela Mara de; Cabral, Francisco Romero; Souza, Jean Gabriel de; Boufleur, Pamela; Marti, Luciana C.; Malheiros, Jackeline Moraes; Cruz, Edgar Ferreira da; Paiva, Fernando Fernandes ; Malheiros, Suzana M. F.; Paiva Neto, Manoel A.; Tannús, Alberto ; Mascarenhas, Sérgio; Silva, Nasjla Saba; Cappellano, Andrea Maria; Petrilli, Antonio Sérgio; Chudzinski-Tavassi, Ana Marisa; Cavalheiro, Sérgio
Source: Oncotarget. Unidade: IFSC
Subjects: NEOPLASIAS CEREBRAIS, MONITORAMENTO, CULTURA DE CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVON, Lorena Favaro et al. Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology. Oncotarget, v. 9, n. 31, p. 21731-21743, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.24932. Acesso em: 18 nov. 2024.
APA
Pavon, L. F., Sibov, T. T., Toledo, S. R. C. de, Oliveira, D. M. de, Cabral, F. R., Souza, J. G. de, et al. (2018). Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology. Oncotarget, 9( 31), 21731-21743. doi:10.18632/oncotarget.24932
NLM
Pavon LF, Sibov TT, Toledo SRC de, Oliveira DM de, Cabral FR, Souza JG de, Boufleur P, Marti LC, Malheiros JM, Cruz EF da, Paiva FF, Malheiros SMF, Paiva Neto MA, Tannús A, Mascarenhas S, Silva NS, Cappellano AM, Petrilli AS, Chudzinski-Tavassi AM, Cavalheiro S. Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology [Internet]. Oncotarget. 2018 ; 9( 31): 21731-21743.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.24932
Vancouver
Pavon LF, Sibov TT, Toledo SRC de, Oliveira DM de, Cabral FR, Souza JG de, Boufleur P, Marti LC, Malheiros JM, Cruz EF da, Paiva FF, Malheiros SMF, Paiva Neto MA, Tannús A, Mascarenhas S, Silva NS, Cappellano AM, Petrilli AS, Chudzinski-Tavassi AM, Cavalheiro S. Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology [Internet]. Oncotarget. 2018 ; 9( 31): 21731-21743.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.24932
Artigo de periodico
Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report (2018)
Mendonça, U. B. T. de; Cernea, Claudio Roberto; Matos, L. L; Lima, R. R. M. A
Source: Oncotarget. Unidade: FM
Subjects: MELANOMA, NEOPLASIAS DE CABEÇA E PESCOÇO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, U. B. T. de et al. Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report. Oncotarget, v. 9, n. 33, p. 22886-22894, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25094. Acesso em: 18 nov. 2024.
APA
Mendonça, U. B. T. de, Cernea, C. R., Matos, L. L., & Lima, R. R. M. A. (2018). Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report. Oncotarget, 9( 33), 22886-22894. doi:10.18632/oncotarget.25094
NLM
Mendonça UBT de, Cernea CR, Matos LL, Lima RRMA. Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report [Internet]. Oncotarget. 2018 ; 9( 33): 22886-22894.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25094
Vancouver
Mendonça UBT de, Cernea CR, Matos LL, Lima RRMA. Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report [Internet]. Oncotarget. 2018 ; 9( 33): 22886-22894.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25094
Artigo de periodico
Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report (2018)
Favero, Giovani Marino; Paz, Jessica Liliane; Otake, Andréia Hanada; Maria, Durvanei Augusto; Caldini, Elia Tamaso Espin Garcia; Medeiros, Raphael Salles Scortegagna de; Deus, Débora F; Chammas, Roger; Maranhão, Raul Cavalcante ; Bydlowski, Sérgio Paulo
Source: Oncotarget. Unidades: FM, FCF
Subjects: MELANOMA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAVERO, Giovani Marino et al. Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report. Oncotarget, v. 9, n. 18, p. 14160-14174, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.24389. Acesso em: 18 nov. 2024.
APA
Favero, G. M., Paz, J. L., Otake, A. H., Maria, D. A., Caldini, E. T. E. G., Medeiros, R. S. S. de, et al. (2018). Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report. Oncotarget, 9( 18), 14160-14174. doi:10.18632/oncotarget.24389
NLM
Favero GM, Paz JL, Otake AH, Maria DA, Caldini ETEG, Medeiros RSS de, Deus DF, Chammas R, Maranhão RC, Bydlowski SP. Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report [Internet]. Oncotarget. 2018 ; 9( 18): 14160-14174.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.24389
Vancouver
Favero GM, Paz JL, Otake AH, Maria DA, Caldini ETEG, Medeiros RSS de, Deus DF, Chammas R, Maranhão RC, Bydlowski SP. Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report [Internet]. Oncotarget. 2018 ; 9( 18): 14160-14174.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.24389
Artigo de periodico
Somatic mutations in early onset luminal breast cancer (2018)
Encinas, G.; Sabelnykova, V. Y.; Lyra, E. C. de; Katayama, Maria Lúcia Hirata; Maistro, S; Valle, P. W. M. V; Pereira, G. F. L; Rodrigues, L. M; Serio, P. A. M. P; Gouvêa, A. C. R. C. de; Pasini, Fatima Solange; Brentani, Maria Mitzi; Chammas, Roger; Folgueira, Maria Aparecida Azevedo Koike
Source: Oncotarget. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, MUTAÇÃO GENÉTICA, JOVENS, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENCINAS, G. et al. Somatic mutations in early onset luminal breast cancer. Oncotarget, v. 9, n. 32, p. 22460-22479, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25123. Acesso em: 18 nov. 2024.
APA
Encinas, G., Sabelnykova, V. Y., Lyra, E. C. de, Katayama, M. L. H., Maistro, S., Valle, P. W. M. V., et al. (2018). Somatic mutations in early onset luminal breast cancer. Oncotarget, 9( 32), 22460-22479. doi:10.18632/oncotarget.25123
NLM
Encinas G, Sabelnykova VY, Lyra EC de, Katayama MLH, Maistro S, Valle PWMV, Pereira GFL, Rodrigues LM, Serio PAMP, Gouvêa ACRC de, Pasini FS, Brentani MM, Chammas R, Folgueira MAAK. Somatic mutations in early onset luminal breast cancer [Internet]. Oncotarget. 2018 ; 9( 32): 22460-22479.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25123
Vancouver
Encinas G, Sabelnykova VY, Lyra EC de, Katayama MLH, Maistro S, Valle PWMV, Pereira GFL, Rodrigues LM, Serio PAMP, Gouvêa ACRC de, Pasini FS, Brentani MM, Chammas R, Folgueira MAAK. Somatic mutations in early onset luminal breast cancer [Internet]. Oncotarget. 2018 ; 9( 32): 22460-22479.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25123
Artigo de periodico
Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy (2018)
Bustos, S. O; Pereira, G. J. S; Saito, R. F; Gil, C. D; Zanatta, D. B; Smaili, S. S; Chammas, Roger
Source: Oncotarget. Unidade: FM
Subjects: MELANOMA, LECTINAS, INIBIDORES DE ENZIMAS, PRIVAÇÃO DE ALIMENTOS, FAGOCITOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUSTOS, S. O et al. Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy. Oncotarget, v. 9, n. 18, p. 14567-14579, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.24516. Acesso em: 18 nov. 2024.
APA
Bustos, S. O., Pereira, G. J. S., Saito, R. F., Gil, C. D., Zanatta, D. B., Smaili, S. S., & Chammas, R. (2018). Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy. Oncotarget, 9( 18), 14567-14579. doi:10.18632/oncotarget.24516
NLM
Bustos SO, Pereira GJS, Saito RF, Gil CD, Zanatta DB, Smaili SS, Chammas R. Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy [Internet]. Oncotarget. 2018 ; 9( 18): 14567-14579.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.24516
Vancouver
Bustos SO, Pereira GJS, Saito RF, Gil CD, Zanatta DB, Smaili SS, Chammas R. Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy [Internet]. Oncotarget. 2018 ; 9( 18): 14567-14579.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.24516
Artigo de periodico
Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality (2018)
Silva, I. da; Vieira, R. C; Stella, C; Loturco, E; Carvalho, A. L; Veo, C; Neto, C; Silva, S. M; D'amora, P; Salzgeber, M; Maciel, Gustavo Arantes Rosa; Baracat, Edmund Chada; Silva, Clovis Artur Almeida da
Source: Oncotarget. Unidade: FM
Subjects: ERROS INATOS DO METABOLISMO, NEOPLASIAS MAMÁRIAS, SOBREVIDA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, I. da et al. Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality. Oncotarget, v. 9, n. 60, p. 31664-31681, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25839. Acesso em: 18 nov. 2024.
APA
Silva, I. da, Vieira, R. C., Stella, C., Loturco, E., Carvalho, A. L., Veo, C., et al. (2018). Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality. Oncotarget, 9( 60), 31664-31681. doi:10.18632/oncotarget.25839
NLM
Silva I da, Vieira RC, Stella C, Loturco E, Carvalho AL, Veo C, Neto C, Silva SM, D'amora P, Salzgeber M, Maciel GAR, Baracat EC, Silva CAA da. Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality [Internet]. Oncotarget. 2018 ; 9( 60): 31664-31681.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25839
Vancouver
Silva I da, Vieira RC, Stella C, Loturco E, Carvalho AL, Veo C, Neto C, Silva SM, D'amora P, Salzgeber M, Maciel GAR, Baracat EC, Silva CAA da. Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality [Internet]. Oncotarget. 2018 ; 9( 60): 31664-31681.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25839
Artigo de periodico
ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate (2018)
Amôr, Nádia Ghinelli ; Oliveira, Carine Ervolino de; Gasparoto, Thaís Helena ; Vilas Boas, Vanessa Garcia ; Perri, Graziela ; Kaneno, Ramon; Lara, Vanessa Soares ; Garlet, Gustavo Pompermaier ; Silva, João Santana da ; Martins, Gislaine Aparecida; Hogaboam, Cory ; Cavassani, Karen Angelica; Campanelli, Ana Paula
Source: Oncotarget. Unidades: FOB, FMRP
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, CAMUNDONGOS, INTERLEUCINAS, CARCINÓGENOS QUÍMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMÔR, Nádia Ghinelli et al. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate. Oncotarget, v. 9, n. 56, p. 30894-30904, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.30894. Acesso em: 18 nov. 2024.
APA
Amôr, N. G., Oliveira, C. E. de, Gasparoto, T. H., Vilas Boas, V. G., Perri, G., Kaneno, R., et al. (2018). ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate. Oncotarget, 9( 56), 30894-30904. doi:10.18632/oncotarget.30894
NLM
Amôr NG, Oliveira CE de, Gasparoto TH, Vilas Boas VG, Perri G, Kaneno R, Lara VS, Garlet GP, Silva JS da, Martins GA, Hogaboam C, Cavassani KA, Campanelli AP. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate [Internet]. Oncotarget. 2018 ; 9( 56): 30894-30904.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.30894
Vancouver
Amôr NG, Oliveira CE de, Gasparoto TH, Vilas Boas VG, Perri G, Kaneno R, Lara VS, Garlet GP, Silva JS da, Martins GA, Hogaboam C, Cavassani KA, Campanelli AP. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate [Internet]. Oncotarget. 2018 ; 9( 56): 30894-30904.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.30894

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation